Maximum quantity allowed is 999
请选择数量
CAS RN: 171599-83-0 | 产品编码: S0986
Sildenafil Citrate
×
![]()
×
纯度/分析方法: >98.0%(HPLC)
别名：
- 枸橼酸西地那非
- 1-[[3-(4,7-二氢-1-甲基-7-氧代-3-丙基-1H-吡唑并[4,3-d]嘧啶-5-基)-4-乙氧基苯基]磺酰基]-4-甲基哌嗪柠檬酸盐
- 5-[2-乙氧基-5-[(4-甲基哌嗪-1-基)磺酰基]苯基]-1-甲基-3-丙基-1H-吡唑并[4,3-d]嘧啶-7(6H)-酮柠檬酸盐
- 1-[[3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine Citrate
- 5-[2-Ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl]-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one Citrate
产品文档：
| 产品编码 | S0986 |
纯度/分析方法 
|
>98.0%(HPLC) |
| 分子式/分子量 | C__2__2H__3__0N__6O__4S·C__6H__8O__7 = 666.70 |
| 外观与形状（20°C） | 固体 |
| 储存温度
|
室温 (15°C以下阴凉干燥处) |
| 包装和容器
|
100MG-Glass Bottle with Plastic Insert （查看图片）, 1G-Glass Bottle with Plastic Insert （查看图片）, 25MG-Glass Bottle with Plastic Insert （查看图片） |
| CAS RN | 171599-83-0 |
| 相关CAS RN
|
139755-83-2 |
| Reaxys-RN | 9035645 |
| PubChem物质ID | 354333548 |
| Merck Index (14) | 8489 |
| MDL编号 | MFCD09026931 |
技术规格
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 97.0 % |
物性（参考值）
| 熔点 | 192 °C(dec.) |
| 溶解性（不溶于） | 乙醚 |
GHS
| 象形图 |
|
| 信号词 | Danger |
| 危险性说明 | H315 : Causes skin irritation. H319 : Causes serious eye irritation. H370 : Causes damage to organs. H372 : Causes damage to organs through prolonged or repeated exposure. |
| 防范说明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P260 : Do not breathe dust/ fume/ gas/ mist/ vapors/ spray. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P311 : IF exposed or concerned: Call a POISON CENTER/doctor. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. P405 : Store locked up. |
相关法规
| RTECS# | TL4284390 |
运输信息
| HS编码* | 2935.90-000 |
应用
Sildenafil Citrate: A cGMP – Specific PDE5 Inhibitor
Sildenafil citrate is a selective inhibitor of cyclic guanosine monophosphate (cGMP) - specific phosphodiesterase type 5 (PDE5) which is the predominant PDE isoenzyme in human corpora cavernosa. In there, nitric oxide (NO) activates the enzyme guanylate cyclase, which results in increased levels of cGMP. Sildenafil enhances the effect of NO by inhibiting PDE5, which is responsible for degradation of cGMP in the corpus cavernosum. Recently, sildenafil citrate has been indicated for the treatment of pulmonary arterial hypertension and Alzheimer's disease et al.For reference, we also have related compounds/synthetic intermediates [E1134] [M2773] of sildenafil. (The product is for research purpose only.)
References
- Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isoenzymes
- Cyclic GMP phosphodiesterase-5: Target of sildenafil (a review)
- Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man
- Sildenafil citrate therapy for pulmonary arterial hypertension
- Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-β load in an Alzheimer's disease mouse model
- Versatile effects of sildenafil: recent pharmacological applications (a review)
PubMed Literature
技术文章
产品文档 (部分产品的分析图谱无法提供，敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助，请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注：该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉，您搜索的分析图谱无法提供。